Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife - The Whitehall II study

被引:106
|
作者
Singh-Manoux, Archana [1 ,2 ]
Gimeno, David [1 ]
Kivimaki, Mika [1 ]
Brunner, Eric [1 ]
Marmot, Michael G. [1 ]
机构
[1] UCL, INSERM, U687 IFR69, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England
[2] Hop Ste Perine, AP HP, Ctr Gerontol, Paris, France
基金
英国医学研究理事会;
关键词
HDL cholesterol; memory; lipids; Whitehall II;
D O I
10.1161/ATVBAHA.108.163998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - The purpose of this study was to examine the relationship between fasting serum lipids and short-term verbal memory in middle-aged adults. Methods and Results - Total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides, and memory were measured twice, at mean ages 55 and 61, in 3673 male and female participants of the Whitehall II study. Short-term verbal memory was assessed using a 20-word list. Logistic regression was used to model associations between ATP-III categories of lipids and memory deficit ( recall of <= 4 words) and decline ( decrease of >= 2 words). Analyses were adjusted for education, occupational position, coronary heart disease, stroke, hypertension, use of medication, diabetes, smoking, and alcohol consumption. Compared to high HDL-C (>= 60 mg/dL), low HDL-C (<40 mg/dL) was associated with greater odds of memory deficit at the first ( OR = 1.27; 95% confidence interval [CI] = 0.91 to 1.77) and second wave of this study ( OR = 1.53; 95% CI = 1.04 to 2.25) in fully adjusted analysis. Decrease in HDL-C over the 5-year follow-up period was associated with decline in memory in the adjusted analysis ( OR = 1.61; 95% CI = 1.19 to 2.16); no interaction with APOE e4 status was present. Conclusions - HDL-C levels are potentially modifiable, and our results suggest that low HDL-C is associated with poor memory and decline in memory in middle-aged adults.
引用
收藏
页码:1556 / 1562
页数:7
相关论文
共 50 条
  • [21] Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study
    Bouillon, Kim
    Singh-Manoux, Archana
    Jokela, Markus
    Shipley, Martin J.
    Batty, G. David
    Brunner, Eric J.
    Sabia, Severine
    Tabak, Adam G.
    Akbaraly, Tasnime
    Ferrie, Jane E.
    Kivimaki, Mika
    HEART, 2011, 97 (11) : 923 - 930
  • [22] Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy Results of the ADVANCE study
    Morton, Jamie
    Zoungas, Sophia
    Li, Qiang
    Patel, Anushka A.
    Chalmers, John
    Woodward, Mark
    Celermajer, David S.
    Beulens, Joline W. J.
    Stolk, Ronald P.
    Glasziou, Paul
    Ng, Martin K. C.
    DIABETES CARE, 2012, 35 (11) : 2201 - 2206
  • [23] TRAJECTORIES OF THE FRAMINGHAM GENERAL CARDIOVASCULAR RISK PROFILE IN MIDLIFE AND POOR MOTOR FUNCTION LATER IN LIFE: THE WHITEHALL II STUDY
    Elbaz, A.
    Shipley, M.
    Nabi, H.
    Brunner, E. J.
    Kivimaki, M.
    Singh-Manoux, A.
    GERONTOLOGIST, 2013, 53 : 168 - 168
  • [24] Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: The Whitehall II study
    Elbaz, Alexis
    Shipley, Martin J.
    Nabi, Hermann
    Brunner, Eric J.
    Kivimaki, Mika
    Singh-Manoux, Archana
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (01) : 96 - 102
  • [25] Working while ill as a risk factor for serious coronary events:: The Whitehall II study
    Kivimäki, M
    Head, J
    Ferrie, JE
    Hemingway, H
    Shipley, MJ
    Vahtera, J
    Marmot, MG
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2005, 95 (01) : 98 - 102
  • [26] Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study
    Tuligenga, Richard H.
    Dugravot, Aline
    Tabak, Adam G.
    Elbaz, Alexis
    Brunner, Eric J.
    Kivimaeki, Mika
    Singh-Manoux, Archana
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (03): : 228 - 235
  • [27] ASSOCIATION BETWEEN SMOKING HISTORY AND COGNITIVE DECLINE IN THE WHITEHALL II STUDY
    Sabia, S.
    Elbaz, A.
    Dugravot, A.
    Head, J.
    Shipley, M.
    Hagger-Johnson, G.
    Kivimaki, M.
    Singh-Manoux, A.
    GERONTOLOGIST, 2011, 51 : 332 - 332
  • [28] Does cognition predict mortality in midlife? Results from the Whitehall II cohort study
    Sabia, Severine
    Gueguen, Alice
    Marmot, Michael G.
    Shipley, Martin J.
    Ankri, Joel
    Singh-Manoux, Archana
    NEUROBIOLOGY OF AGING, 2010, 31 (04) : 688 - 695
  • [29] Obesity phenotypes in midlife and cognition in early old age The Whitehall II cohort study
    Singh-Manoux, Archana
    Czernichow, Sebastien
    Elbaz, Alexis
    Dugravot, Aline
    Sabia, Severine
    Hagger-Johnson, Gareth
    Kaffashian, Sara
    Zins, Marie
    Brunner, Eric J.
    Nabi, Hermann
    Kivimaeki, Mika
    NEUROLOGY, 2012, 79 (08) : 755 - 762
  • [30] Smoking history and cognitive function in late midlife: evidence from the Whitehall II study
    Sabia, S.
    Marmot, M.
    Dufouil, C.
    Singh-Manoux, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2007, 17 : 82 - 82